Sarepta Therapeutics (SRPT) Soars: Stock Rises 12.8%

Zacks Equity Research

Sarepta Therapeutics, Inc. (SRPT) was a big mover last session, as its shares rose nearly 13% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent downtrend for the company, as the stock is now down over 24% in the past one-month timeframe.

In the last 30 days, the company witnessed one negative estimate revision and the Zacks Consensus Estimate also moved lower, signaling trouble down the road. So make sure to keep an eye on this stock going forward to see if yesterday’s move higher lasts.

Sarepta Therapeutics currently has a Zacks Rank #4 (Sell) while its Earnings ESP is positive.

Other better-ranked stocks in the medical sector include Actelion Ltd. (ALIOF), Illumina Inc. (ILMN) and Curis, Inc. (CRIS). All three sport a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>




SAREPTA THERAPEUTICS DE (SRPT): Free Stock Analysis Report

ACTELION LTD (ALIOF): Free Stock Analysis Report

CURIS INC (CRIS): Free Stock Analysis Report

ILLUMINA INC (ILMN): Free Stock Analysis Report


Zacks Investment Research